img

Global Myasthenia Gravis Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Myasthenia Gravis Market Insights, Forecast to 2034

Myasthenia gravis is a chronic autoimmune, neuromuscular disease that causes weakness in the skeletal muscles (the muscles that connect to your bones and contract to allow body movement in the arms and legs, and allow for breathing).
Market Analysis and InsightsGlobal Myasthenia Gravis Market
Global Myasthenia Gravis market is expected to reach to US$ 1348 million in 2023, with a positive growth of %, compared with US$ 1185 million in 2022. Backed with the increasing demand from downstream industries, Myasthenia Gravis industry is evaluated to reach US$ 1955.9 million in 2033. The CAGR will be 6.4% during 2023 to 2033.
Globally, Myasthenia Gravis key companies include Takeda, Roche, CSL Limited, Baxter International, Novartis, Bausch Health, Grifols, AstraZeneca and Avadel Pharmaceuticals, etc. Takeda, Roche, CSL Limited are top 3 players and held % share in total in 2022.
When considering the consumption regions, % revenue of Myasthenia Gravis were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033 and the share will be % in 2033. Moreover, China, plays a key role in the whole Myasthenia Gravis market and estimated to attract more attentions from industry insiders and investors.
Myasthenia Gravis can be divided into Monoclonal Antibodies, Intravenous Immunoglobulin and Others,, etc. Monoclonal Antibodies is the mainstream product in the market, accounting for % revenue share globally in 2022 and the proportion will be % in 2033.
Myasthenia Gravis is widely used in various fields, such as Hospital Pharmacies, Retail Pharmacies and Online Pharmacies,, etc. Hospital Pharmacies provides greatest supports to the Myasthenia Gravis industry development. In 2022, global % revenue of Myasthenia Gravis went into Hospital Pharmacies filed and the proportion will reach to % in 2033.
Report Covers
This report presents an overview of global Myasthenia Gravis market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Myasthenia Gravis market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Takeda
Roche
CSL Limited
Baxter International
Novartis
Bausch Health
Grifols
AstraZeneca
Avadel Pharmaceuticals
Octapharma
Astellas Pharma
Zydus Lifesciences
Kedrion S.p.A.
Segment by Type
Monoclonal Antibodies
Intravenous Immunoglobulin
Others

Segment by Application


Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Myasthenia Gravis introduction, etc. Myasthenia Gravis Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Myasthenia Gravis
Chapter 13Methodology and Data Sources adopted by MRAResearch

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Myasthenia Gravis Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Monoclonal Antibodies
1.2.3 Intravenous Immunoglobulin
1.2.4 Others
1.3 Market by Application
1.3.1 Global Myasthenia Gravis Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Myasthenia Gravis Market Perspective (2018-2033)
2.2 Global Myasthenia Gravis Growth Trends by Region
2.2.1 Myasthenia Gravis Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Myasthenia Gravis Historic Market Size by Region (2018-2023)
2.2.3 Myasthenia Gravis Forecasted Market Size by Region (2024-2033)
2.3 Myasthenia Gravis Market Dynamics
2.3.1 Myasthenia Gravis Industry Trends
2.3.2 Myasthenia Gravis Market Drivers
2.3.3 Myasthenia Gravis Market Challenges
2.3.4 Myasthenia Gravis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Myasthenia Gravis by Players
3.1.1 Global Myasthenia Gravis Revenue by Players (2018-2023)
3.1.2 Global Myasthenia Gravis Revenue Market Share by Players (2018-2023)
3.2 Global Myasthenia Gravis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Myasthenia Gravis, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Myasthenia Gravis Market Concentration Ratio
3.4.1 Global Myasthenia Gravis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Myasthenia Gravis Revenue in 2022
3.5 Global Key Players of Myasthenia Gravis Head office and Area Served
3.6 Global Key Players of Myasthenia Gravis, Product and Application
3.7 Global Key Players of Myasthenia Gravis, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Myasthenia Gravis Breakdown Data by Type
4.1 Global Myasthenia Gravis Historic Market Size by Type (2018-2023)
4.2 Global Myasthenia Gravis Forecasted Market Size by Type (2024-2033)
5 Myasthenia Gravis Breakdown Data by Application
5.1 Global Myasthenia Gravis Historic Market Size by Application (2018-2023)
5.2 Global Myasthenia Gravis Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Myasthenia Gravis Market Size (2018-2033)
6.2 North America Myasthenia Gravis Market Size by Type
6.2.1 North America Myasthenia Gravis Market Size by Type (2018-2023)
6.2.2 North America Myasthenia Gravis Market Size by Type (2024-2033)
6.2.3 North America Myasthenia Gravis Market Share by Type (2018-2033)
6.3 North America Myasthenia Gravis Market Size by Application
6.3.1 North America Myasthenia Gravis Market Size by Application (2018-2023)
6.3.2 North America Myasthenia Gravis Market Size by Application (2024-2033)
6.3.3 North America Myasthenia Gravis Market Share by Application (2018-2033)
6.4 North America Myasthenia Gravis Market Size by Country
6.4.1 North America Myasthenia Gravis Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America Myasthenia Gravis Market Size by Country (2018-2023)
6.4.3 North America Myasthenia Gravis Market Size by Country (2024-2033)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Myasthenia Gravis Market Size (2018-2033)
7.2 Europe Myasthenia Gravis Market Size by Type
7.2.1 Europe Myasthenia Gravis Market Size by Type (2018-2023)
7.2.2 Europe Myasthenia Gravis Market Size by Type (2024-2033)
7.2.3 Europe Myasthenia Gravis Market Share by Type (2018-2033)
7.3 Europe Myasthenia Gravis Market Size by Application
7.3.1 Europe Myasthenia Gravis Market Size by Application (2018-2023)
7.3.2 Europe Myasthenia Gravis Market Size by Application (2024-2033)
7.3.3 Europe Myasthenia Gravis Market Share by Application (2018-2033)
7.4 Europe Myasthenia Gravis Market Size by Country
7.4.1 Europe Myasthenia Gravis Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe Myasthenia Gravis Market Size by Country (2018-2023)
7.4.3 Europe Myasthenia Gravis Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Myasthenia Gravis Market Size (2018-2033)
8.2 China Myasthenia Gravis Market Size by Type
8.2.1 China Myasthenia Gravis Market Size by Type (2018-2023)
8.2.2 China Myasthenia Gravis Market Size by Type (2024-2033)
8.2.3 China Myasthenia Gravis Market Share by Type (2018-2033)
8.3 China Myasthenia Gravis Market Size by Application
8.3.1 China Myasthenia Gravis Market Size by Application (2018-2023)
8.3.2 China Myasthenia Gravis Market Size by Application (2024-2033)
8.3.3 China Myasthenia Gravis Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Myasthenia Gravis Market Size (2018-2033)
9.2 Asia Myasthenia Gravis Market Size by Type
9.2.1 Asia Myasthenia Gravis Market Size by Type (2018-2023)
9.2.2 Asia Myasthenia Gravis Market Size by Type (2024-2033)
9.2.3 Asia Myasthenia Gravis Market Share by Type (2018-2033)
9.3 Asia Myasthenia Gravis Market Size by Application
9.3.1 Asia Myasthenia Gravis Market Size by Application (2018-2023)
9.3.2 Asia Myasthenia Gravis Market Size by Application (2024-2033)
9.3.3 Asia Myasthenia Gravis Market Share by Application (2018-2033)
9.4 Asia Myasthenia Gravis Market Size by Region
9.4.1 Asia Myasthenia Gravis Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia Myasthenia Gravis Market Size by Region (2018-2023)
9.4.3 Asia Myasthenia Gravis Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Myasthenia Gravis Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Myasthenia Gravis Market Size by Type
10.2.1 Middle East, Africa, and Latin America Myasthenia Gravis Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Myasthenia Gravis Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Myasthenia Gravis Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Myasthenia Gravis Market Size by Application
10.3.1 Middle East, Africa, and Latin America Myasthenia Gravis Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Myasthenia Gravis Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Myasthenia Gravis Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Myasthenia Gravis Market Size by Country
10.4.1 Middle East, Africa, and Latin America Myasthenia Gravis Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America Myasthenia Gravis Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Myasthenia Gravis Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Takeda
11.1.1 Takeda Company Details
11.1.2 Takeda Business Overview
11.1.3 Takeda Myasthenia Gravis Introduction
11.1.4 Takeda Revenue in Myasthenia Gravis Business (2018-2023)
11.1.5 Takeda Recent Developments
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Roche Business Overview
11.2.3 Roche Myasthenia Gravis Introduction
11.2.4 Roche Revenue in Myasthenia Gravis Business (2018-2023)
11.2.5 Roche Recent Developments
11.3 CSL Limited
11.3.1 CSL Limited Company Details
11.3.2 CSL Limited Business Overview
11.3.3 CSL Limited Myasthenia Gravis Introduction
11.3.4 CSL Limited Revenue in Myasthenia Gravis Business (2018-2023)
11.3.5 CSL Limited Recent Developments
11.4 Baxter International
11.4.1 Baxter International Company Details
11.4.2 Baxter International Business Overview
11.4.3 Baxter International Myasthenia Gravis Introduction
11.4.4 Baxter International Revenue in Myasthenia Gravis Business (2018-2023)
11.4.5 Baxter International Recent Developments
11.5 Novartis
11.5.1 Novartis Company Details
11.5.2 Novartis Business Overview
11.5.3 Novartis Myasthenia Gravis Introduction
11.5.4 Novartis Revenue in Myasthenia Gravis Business (2018-2023)
11.5.5 Novartis Recent Developments
11.6 Bausch Health
11.6.1 Bausch Health Company Details
11.6.2 Bausch Health Business Overview
11.6.3 Bausch Health Myasthenia Gravis Introduction
11.6.4 Bausch Health Revenue in Myasthenia Gravis Business (2018-2023)
11.6.5 Bausch Health Recent Developments
11.7 Grifols
11.7.1 Grifols Company Details
11.7.2 Grifols Business Overview
11.7.3 Grifols Myasthenia Gravis Introduction
11.7.4 Grifols Revenue in Myasthenia Gravis Business (2018-2023)
11.7.5 Grifols Recent Developments
11.8 AstraZeneca
11.8.1 AstraZeneca Company Details
11.8.2 AstraZeneca Business Overview
11.8.3 AstraZeneca Myasthenia Gravis Introduction
11.8.4 AstraZeneca Revenue in Myasthenia Gravis Business (2018-2023)
11.8.5 AstraZeneca Recent Developments
11.9 Avadel Pharmaceuticals
11.9.1 Avadel Pharmaceuticals Company Details
11.9.2 Avadel Pharmaceuticals Business Overview
11.9.3 Avadel Pharmaceuticals Myasthenia Gravis Introduction
11.9.4 Avadel Pharmaceuticals Revenue in Myasthenia Gravis Business (2018-2023)
11.9.5 Avadel Pharmaceuticals Recent Developments
11.10 Octapharma
11.10.1 Octapharma Company Details
11.10.2 Octapharma Business Overview
11.10.3 Octapharma Myasthenia Gravis Introduction
11.10.4 Octapharma Revenue in Myasthenia Gravis Business (2018-2023)
11.10.5 Octapharma Recent Developments
11.11 Astellas Pharma
11.11.1 Astellas Pharma Company Details
11.11.2 Astellas Pharma Business Overview
11.11.3 Astellas Pharma Myasthenia Gravis Introduction
11.11.4 Astellas Pharma Revenue in Myasthenia Gravis Business (2018-2023)
11.11.5 Astellas Pharma Recent Developments
11.12 Zydus Lifesciences
11.12.1 Zydus Lifesciences Company Details
11.12.2 Zydus Lifesciences Business Overview
11.12.3 Zydus Lifesciences Myasthenia Gravis Introduction
11.12.4 Zydus Lifesciences Revenue in Myasthenia Gravis Business (2018-2023)
11.12.5 Zydus Lifesciences Recent Developments
11.13 Kedrion S.p.A.
11.13.1 Kedrion S.p.A. Company Details
11.13.2 Kedrion S.p.A. Business Overview
11.13.3 Kedrion S.p.A. Myasthenia Gravis Introduction
11.13.4 Kedrion S.p.A. Revenue in Myasthenia Gravis Business (2018-2023)
11.13.5 Kedrion S.p.A. Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Myasthenia Gravis Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Monoclonal Antibodies
Table 3. Key Players of Intravenous Immunoglobulin
Table 4. Key Players of Others
Table 5. Global Myasthenia Gravis Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 6. Global Myasthenia Gravis Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Myasthenia Gravis Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Myasthenia Gravis Market Share by Region (2018-2023)
Table 9. Global Myasthenia Gravis Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 10. Global Myasthenia Gravis Market Share by Region (2024-2033)
Table 11. Myasthenia Gravis Market Trends
Table 12. Myasthenia Gravis Market Drivers
Table 13. Myasthenia Gravis Market Challenges
Table 14. Myasthenia Gravis Market Restraints
Table 15. Global Myasthenia Gravis Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Myasthenia Gravis Revenue Share by Players (2018-2023)
Table 17. Global Top Myasthenia Gravis by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Myasthenia Gravis as of 2022)
Table 18. Global Myasthenia Gravis Industry Ranking 2021 VS 2022 VS 2023
Table 19. Global 5 Largest Players Market Share by Myasthenia Gravis Revenue (CR5 and HHI) & (2018-2023)
Table 20. Global Key Players of Myasthenia Gravis, Headquarters and Area Served
Table 21. Global Key Players of Myasthenia Gravis, Product and Application
Table 22. Global Key Players of Myasthenia Gravis, Product and Application
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Myasthenia Gravis Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Myasthenia Gravis Revenue Market Share by Type (2018-2023)
Table 26. Global Myasthenia Gravis Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 27. Global Myasthenia Gravis Revenue Market Share by Type (2024-2033)
Table 28. Global Myasthenia Gravis Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Myasthenia Gravis Revenue Share by Application (2018-2023)
Table 30. Global Myasthenia Gravis Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 31. Global Myasthenia Gravis Revenue Share by Application (2024-2033)
Table 32. North America Myasthenia Gravis Market Size by Type (2018-2023) & (US$ Million)
Table 33. North America Myasthenia Gravis Market Size by Type (2024-2033) & (US$ Million)
Table 34. North America Myasthenia Gravis Market Size by Application (2018-2023) & (US$ Million)
Table 35. North America Myasthenia Gravis Market Size by Application (2024-2033) & (US$ Million)
Table 36. North America Myasthenia Gravis Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. North America Myasthenia Gravis Market Size by Country (2018-2023) & (US$ Million)
Table 38. North America Myasthenia Gravis Market Size by Country (2024-2033) & (US$ Million)
Table 39. Europe Myasthenia Gravis Market Size by Type (2018-2023) & (US$ Million)
Table 40. Europe Myasthenia Gravis Market Size by Type (2024-2033) & (US$ Million)
Table 41. Europe Myasthenia Gravis Market Size by Application (2018-2023) & (US$ Million)
Table 42. Europe Myasthenia Gravis Market Size by Application (2024-2033) & (US$ Million)
Table 43. Europe Myasthenia Gravis Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Europe Myasthenia Gravis Market Size by Country (2018-2023) & (US$ Million)
Table 45. Europe Myasthenia Gravis Market Size by Country (2024-2033) & (US$ Million)
Table 46. China Myasthenia Gravis Market Size by Type (2018-2023) & (US$ Million)
Table 47. China Myasthenia Gravis Market Size by Type (2024-2033) & (US$ Million)
Table 48. China Myasthenia Gravis Market Size by Application (2018-2023) & (US$ Million)
Table 49. China Myasthenia Gravis Market Size by Application (2024-2033) & (US$ Million)
Table 50. Asia Myasthenia Gravis Market Size by Type (2018-2023) & (US$ Million)
Table 51. Asia Myasthenia Gravis Market Size by Type (2024-2033) & (US$ Million)
Table 52. Asia Myasthenia Gravis Market Size by Application (2018-2023) & (US$ Million)
Table 53. Asia Myasthenia Gravis Market Size by Application (2024-2033) & (US$ Million)
Table 54. Asia Myasthenia Gravis Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 55. Asia Myasthenia Gravis Market Size by Region (2018-2023) & (US$ Million)
Table 56. Asia Myasthenia Gravis Market Size by Region (2024-2033) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Myasthenia Gravis Market Size by Type (2018-2023) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Myasthenia Gravis Market Size by Type (2024-2033) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Myasthenia Gravis Market Size by Application (2018-2023) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Myasthenia Gravis Market Size by Application (2024-2033) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Myasthenia Gravis Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 62. Middle East, Africa, and Latin America Myasthenia Gravis Market Size by Country (2018-2023) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Myasthenia Gravis Market Size by Country (2024-2033) & (US$ Million)
Table 64. Takeda Company Details
Table 65. Takeda Business Overview
Table 66. Takeda Myasthenia Gravis Product
Table 67. Takeda Revenue in Myasthenia Gravis Business (2018-2023) & (US$ Million)
Table 68. Takeda Recent Developments
Table 69. Roche Company Details
Table 70. Roche Business Overview
Table 71. Roche Myasthenia Gravis Product
Table 72. Roche Revenue in Myasthenia Gravis Business (2018-2023) & (US$ Million)
Table 73. Roche Recent Developments
Table 74. CSL Limited Company Details
Table 75. CSL Limited Business Overview
Table 76. CSL Limited Myasthenia Gravis Product
Table 77. CSL Limited Revenue in Myasthenia Gravis Business (2018-2023) & (US$ Million)
Table 78. CSL Limited Recent Developments
Table 79. Baxter International Company Details
Table 80. Baxter International Business Overview
Table 81. Baxter International Myasthenia Gravis Product
Table 82. Baxter International Revenue in Myasthenia Gravis Business (2018-2023) & (US$ Million)
Table 83. Baxter International Recent Developments
Table 84. Novartis Company Details
Table 85. Novartis Business Overview
Table 86. Novartis Myasthenia Gravis Product
Table 87. Novartis Revenue in Myasthenia Gravis Business (2018-2023) & (US$ Million)
Table 88. Novartis Recent Developments
Table 89. Bausch Health Company Details
Table 90. Bausch Health Business Overview
Table 91. Bausch Health Myasthenia Gravis Product
Table 92. Bausch Health Revenue in Myasthenia Gravis Business (2018-2023) & (US$ Million)
Table 93. Bausch Health Recent Developments
Table 94. Grifols Company Details
Table 95. Grifols Business Overview
Table 96. Grifols Myasthenia Gravis Product
Table 97. Grifols Revenue in Myasthenia Gravis Business (2018-2023) & (US$ Million)
Table 98. Grifols Recent Developments
Table 99. AstraZeneca Company Details
Table 100. AstraZeneca Business Overview
Table 101. AstraZeneca Myasthenia Gravis Product
Table 102. AstraZeneca Revenue in Myasthenia Gravis Business (2018-2023) & (US$ Million)
Table 103. AstraZeneca Recent Developments
Table 104. Avadel Pharmaceuticals Company Details
Table 105. Avadel Pharmaceuticals Business Overview
Table 106. Avadel Pharmaceuticals Myasthenia Gravis Product
Table 107. Avadel Pharmaceuticals Revenue in Myasthenia Gravis Business (2018-2023) & (US$ Million)
Table 108. Avadel Pharmaceuticals Recent Developments
Table 109. Octapharma Company Details
Table 110. Octapharma Business Overview
Table 111. Octapharma Myasthenia Gravis Product
Table 112. Octapharma Revenue in Myasthenia Gravis Business (2018-2023) & (US$ Million)
Table 113. Octapharma Recent Developments
Table 114. Astellas Pharma Company Details
Table 115. Astellas Pharma Business Overview
Table 116. Astellas Pharma Myasthenia Gravis Product
Table 117. Astellas Pharma Revenue in Myasthenia Gravis Business (2018-2023) & (US$ Million)
Table 118. Astellas Pharma Recent Developments
Table 119. Zydus Lifesciences Company Details
Table 120. Zydus Lifesciences Business Overview
Table 121. Zydus Lifesciences Myasthenia Gravis Product
Table 122. Zydus Lifesciences Revenue in Myasthenia Gravis Business (2018-2023) & (US$ Million)
Table 123. Zydus Lifesciences Recent Developments
Table 124. Kedrion S.p.A. Company Details
Table 125. Kedrion S.p.A. Business Overview
Table 126. Kedrion S.p.A. Myasthenia Gravis Product
Table 127. Kedrion S.p.A. Revenue in Myasthenia Gravis Business (2018-2023) & (US$ Million)
Table 128. Kedrion S.p.A. Recent Developments
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Myasthenia Gravis Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global Myasthenia Gravis Market Share by Type: 2022 VS 2033
Figure 3. Monoclonal Antibodies Features
Figure 4. Intravenous Immunoglobulin Features
Figure 5. Others Features
Figure 6. Global Myasthenia Gravis Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 7. Global Myasthenia Gravis Market Share by Application: 2022 VS 2033
Figure 8. Hospital Pharmacies Case Studies
Figure 9. Retail Pharmacies Case Studies
Figure 10. Online Pharmacies Case Studies
Figure 11. Myasthenia Gravis Report Years Considered
Figure 12. Global Myasthenia Gravis Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 13. Global Myasthenia Gravis Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 14. Global Myasthenia Gravis Market Share by Region: 2022 VS 2033
Figure 15. Global Myasthenia Gravis Market Share by Players in 2022
Figure 16. Global Top Myasthenia Gravis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Myasthenia Gravis as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Myasthenia Gravis Revenue in 2022
Figure 18. North America Myasthenia Gravis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. North America Myasthenia Gravis Market Share by Type (2018-2033)
Figure 20. North America Myasthenia Gravis Market Share by Application (2018-2033)
Figure 21. North America Myasthenia Gravis Market Share by Country (2018-2033)
Figure 22. United States Myasthenia Gravis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Canada Myasthenia Gravis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Myasthenia Gravis Market Size YoY (2018-2033) & (US$ Million)
Figure 25. Europe Myasthenia Gravis Market Share by Type (2018-2033)
Figure 26. Europe Myasthenia Gravis Market Share by Application (2018-2033)
Figure 27. Europe Myasthenia Gravis Market Share by Country (2018-2033)
Figure 28. Germany Myasthenia Gravis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. France Myasthenia Gravis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. U.K. Myasthenia Gravis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Italy Myasthenia Gravis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Russia Myasthenia Gravis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Nordic Countries Myasthenia Gravis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. China Myasthenia Gravis Market Size YoY (2018-2033) & (US$ Million)
Figure 35. China Myasthenia Gravis Market Share by Type (2018-2033)
Figure 36. China Myasthenia Gravis Market Share by Application (2018-2033)
Figure 37. Asia Myasthenia Gravis Market Size YoY (2018-2033) & (US$ Million)
Figure 38. Asia Myasthenia Gravis Market Share by Type (2018-2033)
Figure 39. Asia Myasthenia Gravis Market Share by Application (2018-2033)
Figure 40. Asia Myasthenia Gravis Market Share by Region (2018-2033)
Figure 41. Japan Myasthenia Gravis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. South Korea Myasthenia Gravis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. China Taiwan Myasthenia Gravis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Southeast Asia Myasthenia Gravis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. India Myasthenia Gravis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Australia Myasthenia Gravis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Myasthenia Gravis Market Size YoY (2018-2033) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Myasthenia Gravis Market Share by Type (2018-2033)
Figure 49. Middle East, Africa, and Latin America Myasthenia Gravis Market Share by Application (2018-2033)
Figure 50. Middle East, Africa, and Latin America Myasthenia Gravis Market Share by Country (2018-2033)
Figure 51. Brazil Myasthenia Gravis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 52. Mexico Myasthenia Gravis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 53. Turkey Myasthenia Gravis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. Saudi Arabia Myasthenia Gravis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. Israel Myasthenia Gravis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. GCC Countries Myasthenia Gravis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 57. Takeda Revenue Growth Rate in Myasthenia Gravis Business (2018-2023)
Figure 58. Roche Revenue Growth Rate in Myasthenia Gravis Business (2018-2023)
Figure 59. CSL Limited Revenue Growth Rate in Myasthenia Gravis Business (2018-2023)
Figure 60. Baxter International Revenue Growth Rate in Myasthenia Gravis Business (2018-2023)
Figure 61. Novartis Revenue Growth Rate in Myasthenia Gravis Business (2018-2023)
Figure 62. Bausch Health Revenue Growth Rate in Myasthenia Gravis Business (2018-2023)
Figure 63. Grifols Revenue Growth Rate in Myasthenia Gravis Business (2018-2023)
Figure 64. AstraZeneca Revenue Growth Rate in Myasthenia Gravis Business (2018-2023)
Figure 65. Avadel Pharmaceuticals Revenue Growth Rate in Myasthenia Gravis Business (2018-2023)
Figure 66. Octapharma Revenue Growth Rate in Myasthenia Gravis Business (2018-2023)
Figure 67. Astellas Pharma Revenue Growth Rate in Myasthenia Gravis Business (2018-2023)
Figure 68. Zydus Lifesciences Revenue Growth Rate in Myasthenia Gravis Business (2018-2023)
Figure 69. Kedrion S.p.A. Revenue Growth Rate in Myasthenia Gravis Business (2018-2023)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries